Publicacións (34) Publicacións de Raquel Zubizarreta Alberdi

2023

  1. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs

    Nature Medicine, Vol. 29, Núm. 5, pp. 1135-1145

2022

  1. Estratexia para a eliminación da hepatite C como problema de saúde pública en Galicia

    Conselleria de Sanidade

  2. Surgical complications in a population-based colorectal cancer screening program: Incidence and associated factors

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 660-667

2021

  1. Overtreatment in nonmalignant lesions detected in a colorectal cancer screening program: a retrospective cohort study

    BMC Cancer, Vol. 21, Núm. 1

2020

  1. Pt1 colorectal cancer detected in a colorectal cancer mass screening program: Treatment and factors associated with residual and extraluminal disease

    Cancers, Vol. 12, Núm. 9, pp. 1-19

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

2015

  1. Impacto do programa galego de detección precoz do cancro de mama ((PGDPCM) sobre a mortalidade por cancro de mama en Galicia.: Período 1980-2012

    XII Congreso Galego de Estatística e Investigación de Operacións: Lugo, 22-23-24 de outubro de 2015. Actas

  2. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program

    Breast Cancer Research and Treatment, Vol. 154, Núm. 2, pp. 403-415

  3. Walking, biking or sport: How Spanish women attending breast cancer screening meet physical activity recommendations?

    European Journal of Public Health, Vol. 25, Núm. 5, pp. 857-863

2014

  1. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer

    PLoS ONE, Vol. 9, Núm. 2

  2. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme

    PLoS ONE, Vol. 9, Núm. 10

  3. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

    Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997

  4. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

  5. Tumor phenotype and breast density in distinct categories of interval cancer: Results of population-based mammography screening in Spain

    Breast Cancer Research, Vol. 16, Núm. 1

2013

  1. Breast cancer detection risk in screening mammography after a false-positive result

    Cancer Epidemiology, Vol. 37, Núm. 1, pp. 85-90

  2. Cumulative risk of cancer detection in breast cancer screening by protocol strategy

    Breast Cancer Research and Treatment, Vol. 138, Núm. 3, pp. 869-877

  3. Programas de detección precoz de cáncer de mama en España: características y principales resultados

    Medicina Clinica, Vol. 141, Núm. 1, pp. 13-23

  4. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in spain: A retrospective cohort study

    PLoS ONE, Vol. 8, Núm. 12

2012

  1. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening

    New England Journal of Medicine, Vol. 366, Núm. 8, pp. 697-706

  2. Effect of false-positive results on reattendance at breast cancer screening programmes in Spain

    The European Journal of Public Health, Vol. 22, Núm. 3, pp. 404-408